Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Naveen Pemmaraju, MD, Uma Borate, MD, Melhem Solh, MD, Gautam M. Borthakur, MD, Amy E. DeZern, MD, Chao Zhang, PhD, Ben Powell, PhD, Paul Severson, Kerry Inokuchi, Bernice Matusow, Jason Halladay, Ching Hsu, PhD, Paul Watkins, Jackie M. Walling, PhD MD, Athanasios C. Tsiatis, MD, Alice S. Mims, MD

Blood (2019) 134 (Supplement_1): 1391.

https://doi.org/10.1182/blood-2019-127497

Published: 2019

Journal Articles

High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster

Blood (2019) 134 (Supplement_1): 3720.

https://doi.org/10.1182/blood-2019-129276

Published: 2019

Journal Articles

Midostaurin in Adults with Newly Diagnosed FLT3 -Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program

Alexander E. Perl, MD, Kendra L. Sweet, MD, Gail J. Roboz, MD, Stephen A. Strickland, MD, Mark R. Litzow, MD, Gaetano J Bonifacio, MD, Kelly Haines, Alysha Barbera, Das Purkayastha, Andrew Dalovisio, MD

Blood (2018) 132 (Supplement 1): 4038.

https://doi.org/10.1182/blood-2018-99-113608

Published: 2018

Journal Articles

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

Ryan B. Sinit, David M. Aboulafia, MD, Russell K. Dorer, MD PhD

Blood (2018) 132 (Supplement 1): 5340.

https://doi.org/10.1182/blood-2018-99-110278

Published: 2018

Journal Articles

Ibrutinib Can Induce Complete Remissions and Sustained Responses in Refractory Cutaneous or Leg-Type Diffuse Large B-Cell Lymphoma

Johannes Bloehdorn, MD, Stephanie Ellen Weissinger, MD, Anca Sindrilaru, MD, Stefan Schoensteiner, MD, Thorsten Peters, MD, Peter Moeller, MD, Ralf Marienfeld, PhD, Andreas Viardot, MD

Blood (2018) 132 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2018-99-117032

Published: 2018

Journal Articles

Does Mixed Chimerism after Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Impact on Outcome?

Mouhab Ayas, MD, Khawar Siddiqui, Antonette Amao, Abdullah Aljefri, MD, Ali Abdallah Ahmari, MD, Ibrahim A. Ghemlas, MBBS, Hawazen S. Alsaedi, MD, Awatif Alanazi, MD, Amal Al-Seraihy, MD

Blood (2018) 132 (Supplement 1): 4588.

https://doi.org/10.1182/blood-2018-99-112330

Published: 2018

Journal Articles

Results of an Interim Safety Analysis of a Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) in Previously Untreated and Relapsed Patients (Pts) with Multiple Myeloma (MM)

Habte Yimer, MD, Jason Melear, MD, Edward Faber, William I. Bensinger, MD, John M Burke, MD, Sriya Gunawardena, MD, Murphy Sean, Hollee Parros, Yana Lutska, Mohamed Darif, PhD, Anil Londhe, PhD, Ming Qi, Jon Ukropec, Thomas Lin, Robert M. Rifkin, MD

Blood (2017) 130 (Supplement 1): 1839.

https://doi.org/10.1182/blood.V130.Suppl_1.1839.1839

Published: 2017

Journal Articles

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Julie Kanter, MD, Darla Liles, MD, Rodolfo Cancado, MD, PhD, João Friedrisch, MD PhD, Troy H. Guthrie, MD, Jennifer Knight-Madden, MBBS, PhD, Ofelia A. Alvarez, MD, Victor R. Gordeuk, MD, Sandra Gualandro, MD PhD, Marina Pereira Collela, MD PhD, Wally R. Smith, MD, Scott A. Rollins, PhD, Jonathan W. Stocker, PhD, Russell P. Rother, PhD

Blood (2016) 128 (22): 1.

https://doi.org/10.1182/blood.V128.22.1.1

Published: 2016

Journal Articles

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

André Tichelli, MD, Eric Beohou, Myriam Labopin, Gérard Socié, MD PhD, Alicia Rovó, MD, Manuela Badoglio, Anja van Biezen, Grzegorz Basak, MD, Rafael F. Duarte, MD PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2016) 128 (22): 3441.

https://doi.org/10.1182/blood.V128.22.3441.3441

Published: 2016

Journal Articles

Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial

Blood (2016) 128 (22): 59.

https://doi.org/10.1182/blood.V128.22.59.59

Published: 2016

Journal Articles

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

Blood (2015) 126 (23): 5088.

https://doi.org/10.1182/blood.V126.23.5088.5088

Published: 2015

Journal Articles

Prospective Weekly Surveillance Of Respiratory Viruses Using Viral Culture In First 100 Days After Allogeneic Stem Cell Transplantation

Masanori Tsuji, MD, Satsuki Kakiuchi, MD, Hidekazu Nishimura, MD, PhD, Hikari Ota, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hideki Araoka, MD, Hisashi Yamamoto, MD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shigeyoshi Makino, MD, PhD, Akiko Yoneyama, MD, PhD, Chang-Kweng Lim, DVM, PhD, Masayuki Saijo, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2013) 122 (21): 2050.

https://doi.org/10.1182/blood.V122.21.2050.2050

Published: 2013

Journal Articles

Nonacog Alfa: Analysis Of Safety Data From 6 Prospective Clinical Studies In Different Patient Populations With Hemophilia B Treated With Different Therapeutic Modalities

Pablo Rendo, MD, Lynne Smith, MBA, Lee Hsiao-Yu, Frank E. Shafer, MD

Blood (2013) 122 (21): 3604.

https://doi.org/10.1182/blood.V122.21.3604.3604

Published: 2013

Journal Articles

A Phase III Randomized, Double Blind, Placebo Controlled Multi-Center Study Of Panobinostat For Maintenance Of Response In Patients With Hodgkin Lymphoma Who Are At Risk For Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant: Final Results After Early Trial Discontinuation

Bastian von Tresckow, MD, Aleksander Skotnicki, MD, PhD, Igur Lisukov, MD, Shivani Srivastava, MD, David S. Morgan, MD, Franck Morschhauser, MD, PhD, Caterina Stelitano, Jeffrey Szer, BMedSc, MBBS, FRACP, Dennis A. Eichenauer, MD, Jeremy S. Abramson, MD, Anna Sureda, MD, PhD, Christophe Ferme, MD, Andreas Engert, MD

Blood (2013) 122 (21): 4648.

https://doi.org/10.1182/blood.V122.21.4648.4648

Published: 2013

Journal Articles

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Antonio Piga, MD, Silvia Fracchia, MD, Maria Eliana Lai, MD, M Domenica Cappellini, MD, Dany Habr, MD, Antje Wegener, MD, Emmanuel Bouillaud, MSc, Gian Luca Forni, MD

Blood (2012) 120 (21): 3257.

https://doi.org/10.1182/blood.V120.21.3257.3257

Published: 2012

Journal Articles

The Risk of Cancer Following Acute Venous Thromboembolism: A Population-Based Cohort Study

Anne Le-Ngoc, MD, Yunqi Ji, PhD, Vicky Tagalakis, MD, MSc

Blood (2012) 120 (21): 3399.

https://doi.org/10.1182/blood.V120.21.3399.3399

Published: 2012

Journal Articles

Correlation Between Severity of Oral Mucositis and Both Overall and Gut Acute GvHD After High Intensity Conditioning Hematopoietic Stem Cell Transplantation.

Maria Elvira Correa, DDS, Mark M Schubert, DDS, MSD, Barry Storer, PhD, Paul J. Martin, MD, Mary E.D. Flowers, MD

Blood (2012) 120 (21): 3057.

https://doi.org/10.1182/blood.V120.21.3057.3057

Published: 2012

Journal Articles

Factors Affecting Outcome of Related Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia.

Mouhab F Ayas, MD, Khawar Siddiqui, MSc, Amal Al-Seraihy, MD, Hassan El-Solh, MD, Ali Al-Ahmari, MD, Abdulrahman Al-Musa, MD, Ashraf Khairi, MD, Samer Markiz, MD, Hasan Shahin, MD, Viqaruddin Mohammed, Abdullah Al-Jefri, MD

Blood (2012) 120 (21): 3100.

https://doi.org/10.1182/blood.V120.21.3100.3100

Published: 2012

Journal Articles

Human Papillomavirus (HPV)-Attributable Subsequent Neoplasms (SNs) After Hematopoietic Cell Transplantation (HCT) – a Potentially Preventable Outcome

J Berano Teh, Can-Lan Sun, Ph.D, Sharon Wilczynski, Joel Epstein, R. Spielberger, M.D., Ellie Maghami, Wendy Landier, Ph.D., R.N., Liton Francisco, Saro H. Armenian, DO, MPH, Lennie Wong, PhD, Stephen J. Forman, Smita Bhatia, MD, MPH

Blood (2012) 120 (21): 605.

https://doi.org/10.1182/blood.V120.21.605.605

Published: 2012

Journal Articles

Fanconi Anemia: Emerging Therapeutic Opportunities

Markus Grompe, MD, John Postlethwait, Professor, Alan D. D'Andrea, MD, Susan B. Olson, Qingshuo Zhang, Grover C. Bagby, Jr.

Blood (2012) 120 (21): SCI-1.

https://doi.org/10.1182/blood.V120.21.SCI-1.SCI-1

Published: 2012

NARROW

Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster

Midostaurin in Adults with Newly Diagnosed FLT3 -Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

Ibrutinib Can Induce Complete Remissions and Sustained Responses in Refractory Cutaneous or Leg-Type Diffuse Large B-Cell Lymphoma

Does Mixed Chimerism after Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Impact on Outcome?

Results of an Interim Safety Analysis of a Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) in Previously Untreated and Relapsed Patients (Pts) with Multiple Myeloma (MM)

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

Prospective Weekly Surveillance Of Respiratory Viruses Using Viral Culture In First 100 Days After Allogeneic Stem Cell Transplantation

Nonacog Alfa: Analysis Of Safety Data From 6 Prospective Clinical Studies In Different Patient Populations With Hemophilia B Treated With Different Therapeutic Modalities

A Phase III Randomized, Double Blind, Placebo Controlled Multi-Center Study Of Panobinostat For Maintenance Of Response In Patients With Hodgkin Lymphoma Who Are At Risk For Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant: Final Results After Early Trial Discontinuation

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

The Risk of Cancer Following Acute Venous Thromboembolism: A Population-Based Cohort Study

Correlation Between Severity of Oral Mucositis and Both Overall and Gut Acute GvHD After High Intensity Conditioning Hematopoietic Stem Cell Transplantation.

Factors Affecting Outcome of Related Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia.

Human Papillomavirus (HPV)-Attributable Subsequent Neoplasms (SNs) After Hematopoietic Cell Transplantation (HCT) – a Potentially Preventable Outcome

Fanconi Anemia: Emerging Therapeutic Opportunities

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only